Loading...
Novanta reported a 7% increase in GAAP revenue to $219 million for the first quarter of 2023. The company's strong performance was driven by growth in medical end-markets and effective execution by the teams.
GAAP Revenue increased 7% to $219 million.
GAAP Net Income was $18 million.
Adjusted Earnings Per Share reached $0.74.
Adjusted EBITDA amounted to $47 million.
For the second quarter of 2023, the Company expects GAAP revenue of approximately $222 million to $225 million. The Company expects Adjusted EBITDA to be in the range of $47 million to $49 million and Adjusted Diluted EPS to be in the range of $0.70 to $0.74.